Related Experiment Video
Updated: May 28, 2026

Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi
Published on: September 28, 2022
Ceftriaxone-induced hemolysis in a child with Lyme arthritis: a case for antimicrobial stewardship
Sarah R Boggs1, Kenji M Cunnion, Reem H Raafat
1Division of Infectious Diseases, Children's Hospital of The King's Daughters and Eastern Virginia Medical School, Norfolk, VA 23508, USA. boggssr@chkd.org
Insights
Antimicrobial stewardship is crucial. A young patient developed severe complications, including autoimmune hemolytic anemia and renal failure, after intravenous ceftriaxone treatment for Lyme arthritis, emphasizing careful drug selection.
Area of Science:
- Infectious Diseases
- Pharmacology
- Nephrology
Background:
- The Infectious Diseases Society of America (IDSA) 2006 guidelines recommended oral doxycycline for Lyme arthritis.
- Lyme arthritis is a common manifestation of late-stage Lyme disease.
Observation:
- A pediatric patient received intravenous ceftriaxone for Lyme arthritis.
- The patient subsequently developed drug-induced autoimmune hemolytic anemia (AIHA).
- The patient also experienced acute renal failure.
Findings:
- Intravenous ceftriaxone, though effective for Lyme disease, can precipitate rare but severe adverse drug events.
- AIHA and renal failure represent significant, potentially life-threatening sequelae.
- This case underscores the critical need for judicious antibiotic use.
Implications:
- Highlights the importance of antimicrobial stewardship in pediatric infectious disease management.
- Suggests a need for heightened awareness of potential severe adverse events with broad-spectrum antibiotics.
- Emphasizes the balance between effective treatment and minimizing iatrogenic complications.
Abstract:
Guidelines for the treatment of Lyme arthritis were published by the Infectious Diseases Society of America in 2006 and recommended oral doxycycline for initial therapy. We report here the case of a young girl treated with intravenous ceftriaxone who subsequently developed drug-induced autoimmune hemolytic anemia and renal failure. Her severe sequelae highlight the importance of antimicrobial stewardship. We review here the goals of antimicrobial stewardship and several strategies for achieving them. In addition, we briefly discuss the rare adverse drug event experienced by our patient.
Related Concept Videos
Rocky Mountain Spotted Fever
Inhibitors of Bacterial DNA Synthesis
Clinical Significance of Antibiotic Resistance
Endocarditis III: Medical Management
Streptococcal Pharyngitis
Acute Pyelonephritis II: Diagnostic Studies and Management